CRC-P GRANT SECURED BY TESSARA THERAPEUTICS, PSYLO, AND THE UNIVERSITY OF SYDNEY TO ADVANCE BRAIN-R...
Innovative biotech company pioneers PSYLO-100X, a non-hallucinogenic neuroplastogen with promising ...
SINGAPORE, Oct. 31, 2023 /PRNewswire/ -- Psylo, a biotechnology start-up pioneering the development...
The Sponsored Research Agreement will help advance antidepressant treatments for patients in need ...